DCF — METHODIST MIDLOTHIAN MEDICAL CENTER
Enterprise Value: $5.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$5.9M
Enterprise Value
$-0.1M
PV of Cash Flows
$5.9M
PV of Terminal Value
$9.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $71.4M | $2.3M | 3.0% | $-0.9M | $-0.8M |
| Year 2 | $73.5M | $3.1M | 4.0% | $-0.3M | $-0.3M |
| Year 3 | $75.7M | $4.0M | 5.0% | $0.2M | $0.2M |
| Year 4 | $78.0M | $4.5M | 6.0% | $0.5M | $0.4M |
| Year 5 | $80.3M | $4.8M | 6.0% | $0.7M | $0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $5.9M. Terminal value accounts for 101% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$69.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02721210556151061
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5